Regulon

Regulon: R-2705

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
192.49437114Pr-9Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
6591 ENSG00000019549 SNAI2 O43623
8974 ENSG00000072682 P4HA2 O15460
2192 ENSG00000077942 FBLN1 P23142
22795 ENSG00000087303 NID2 Q14112
5358 ENSG00000102024 PLS3 P13797
5118 ENSG00000106333 PCOLCE Q15113
5054 ENSG00000106366 SERPINE1 P05121
4124 ENSG00000112893 MAN2A1 Q16706
2335 ENSG00000115414 FN1 P02751
2274 ENSG00000115641 FHL2 Q14192
4060 ENSG00000139329 LUM P51884
8038 ENSG00000148848 ADAM12 O43184
5937 ENSG00000153250 RBMS1 P29558
9510 ENSG00000154734 ADAMTS1 Q9UHI8
25903 ENSG00000162745 OLFML2B Q68BL8
1278 ENSG00000164692 COL1A2 P08123
1281 ENSG00000168542 COL3A1 P02461
79642 ENSG00000180801 ARSJ Q5FYB0
1290 ENSG00000204262 COL5A2 P05997

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
L19IL2FN1AntibodyBINDING AGENTFibronectin binding agent30
AS-1409FN1AntibodyBINDING AGENTFibronectin binding agent10
ALEPLASININSERPINE1Small moleculeINHIBITORPlasminogen activator inhibitor-1 inhibitor10
L19TNFAFN1AntibodyBINDING AGENTFibronectin binding agent20
L19SIP 131IFN1AntibodyOTHERFibronectin other20
COLLAGENASE CLOSTRIDIUM HISTOLYTICUMCOL1A2EnzymeHYDROLYTIC ENZYMECollagen hydrolytic enzyme40
OCRIPLASMINLAMA2EnzymePROTEOLYTIC ENZYMEFibronectin proteolytic enzyme40

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-2705

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-00358COL6A3up-regulatesNFATC4activatesR-2705104Drugs (7)
CMF-00419MUC16down-regulatesNFATC4activatesR-2705101Drugs (7)
CMF-00775TPTE2down-regulatesNFATC4activatesR-2705103Drugs (7)
CMF-02357KCNH6down-regulatesNFATC4activatesR-2705102Drugs (7)
CMF-07149ATRXdown-regulatesNFATC4activatesR-2705107Drugs (7)
CMF-14120HEATR7B2down-regulatesNFATC4activatesR-2705102Drugs (7)
CMF-16260USP11down-regulatesNFATC4activatesR-2705104Drugs (7)
CMF-19568NF1up-regulatesNFATC4activatesR-2705108Drugs (7)
CMF-20281ENAMdown-regulatesNFATC4activatesR-2705102Drugs (7)
CMF-22182PDGFRAdown-regulatesNFATC4activatesR-2705104Drugs (7)
CMF-22940IDH1down-regulatesNFATC4activatesR-2705107Drugs (7)
CMF-26408MAGEB1down-regulatesNFATC4activatesR-2705103Drugs (7)
CMF-30552JHDM1Ddown-regulatesNFATC4activatesR-2705104Drugs (7)
CMF-30905NPY5Rdown-regulatesNFATC4activatesR-2705102Drugs (7)